Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Int J Antimicrob Agents
; 55(6): 105969, 2020 Jun.
Article
in English
| MEDLINE | ID: covidwho-143205
ABSTRACT
Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Coronavirus Infections
/
Drug Repositioning
/
Betacoronavirus
Limits:
Humans
Language:
English
Journal:
Int J Antimicrob Agents
Year:
2020
Document Type:
Article
Affiliation country:
J.ijantimicag.2020.105969
Similar
MEDLINE
...
LILACS
LIS